Working with TipRanks
Follow Us
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
ThermoGenesis Holdings (THMO)
NASDAQ:THMO
RESEARCH TOOLSreports
ThermoGenesis Holdings (THMO) Stock Price & Analysis
316 Followers
THMO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.03 - $14.40
Previous Close$1.38
Volume45.64K
Average Volume (3M)54.21K
Market Cap
$3.43M
Enterprise Value$4.93M
Total Cash (Recent Filing)$4.45M
Total Debt (Recent Filing)$7.16M
Price to Earnings (P/E)-0.1
Beta0.89
Next Earnings
Nov 16, 2023EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-12.95
Shares Outstanding2,482,298
10 Day Avg. Volume59,283
30 Day Avg. Volume54,207
Standard Deviation2.80
R-Squared0.01
Alpha0.39
Financial Highlights & Ratios
Price to Book (P/B)1.92
Price to Sales (P/S)1.51
Price to Cash Flow (P/CF)-1.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.51
Enterprise Value/Gross Profit-0.63
Enterprise Value/Ebitda0.70
Forecast
1Y Price Target
$5.00Price Target Upside313.22% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
ThermoGenesis Holdings News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Insights
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
THMO FAQ
What was ThermoGenesis Holdings’s price range in the past 12 months?
ThermoGenesis Holdings lowest stock price was $1.03 and its highest was $14.40 in the past 12 months.
What is ThermoGenesis Holdings’s market cap?
Currently, no data Available
When is ThermoGenesis Holdings’s upcoming earnings report date?
ThermoGenesis Holdings’s upcoming earnings report date is Nov 16, 2023 which is in 44 days.
How were ThermoGenesis Holdings’s earnings last quarter?
ThermoGenesis Holdings released its earnings results on Aug 10, 2023. The company reported -$0.91 earnings per share for the quarter, missing the consensus estimate of $0.01 by -$0.92.
Is ThermoGenesis Holdings overvalued?
According to Wall Street analysts ThermoGenesis Holdings’s price is currently Undervalued.
Does ThermoGenesis Holdings pay dividends?
ThermoGenesis Holdings does not currently pay dividends.
What is ThermoGenesis Holdings’s EPS estimate?
ThermoGenesis Holdings’s EPS estimate is -$0.21.
How many shares outstanding does ThermoGenesis Holdings have?
ThermoGenesis Holdings has 2,482,298 shares outstanding.
What happened to ThermoGenesis Holdings’s price movement after its last earnings report?
ThermoGenesis Holdings reported an EPS of -$0.91 in its last earnings report, missing expectations of $0.01. Following the earnings report the stock price went down -11.594%.
Which hedge fund is a major shareholder of ThermoGenesis Holdings?
Currently, no hedge funds are holding shares in THMO
---
ThermoGenesis Holdings Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$5.00 (313.22% Upside)
$5.00 (313.22% Upside)
Insider Transactions
Bought Shares
Worth $700.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-86.95%
12-Months-Change
Fundamentals
Return on Equity
-280.02%
Trailing 12-Months
Asset Growth
-17.44%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
ThermoGenesis Holdings
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization and marketing of automated technologies for cell-based therapies for use in regenerative medicine. It operates through the following segments: Device and Clinical Development. The Device segment includes development and commercialization of automated systems that provide good manufacturing practice, clinical grade cell-banking, cell-processing and cell-based therapeutics. The Clinical Development segment develops autologous stem cell-based therapeutics that address significant unmet medical needs for the vascular, cardiology, and orthopedic markets. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
---
Top 5 ETFs holding THMO
iShares Core S&P Total U.S. Stock Market ETF
$1.35
Up to five ETFs with an Outperform Smart Score that hold THMO. The ETFs are listed according to market value of THMO within the ETF
---